Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.8136
-0.0576 (-6.61%)
At close: May 15, 2026, 4:00 PM EDT
0.8100
-0.0036 (-0.44%)
Pre-market: May 18, 2026, 5:12 AM EDT

Skye Bioscience Stock Forecast

SKYE's stock price has decreased by -57.18% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 8 analysts polled by S&P Global, Skye Bioscience stock has a consensus rating of "Buy" and an average price target of $7.71. The average 1-year stock price forecast is 847.64% higher than the current stock price, while the lowest is $2.00 (+145.82%) and the highest is $20 (+2,358.21%).

Price Target: $7.71 (+847.64%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$2.00$7.71$6.00$20
Change+145.82%+847.64%+637.46%+2358.2%
* Price targets were last updated on Sep 30, 2025.

Analyst Ratings

The average analyst rating for Skye Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy222221
Buy444442
Hold000000
Sell000000
Strong Sell000000
Total666663

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$20
Strong BuyInitiates$20+2,358.21%Sep 30, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Initiates
$10
BuyInitiates$10+1,129.11%Aug 15, 2025
JMP Securities
JMP Securities
Buy
Reiterates
$15
BuyReiterates$15+1,743.66%Jun 24, 2025
Craig-Hallum
Craig-Hallum
Strong Buy
Maintains
$18$14
Strong BuyMaintains$18$14+1,620.75%Mar 21, 2025
Citizens Capital Markets
Citizens Capital Markets
Buy
Reiterates
$15
BuyReiterates$15+1,743.66%Mar 21, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.98
from -1.41
EPS Next Year
-1.13
from -0.98
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-5.24-8.77-5.37-0.73-1.41-0.98-1.13
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1010
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030203120322033
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030203120322033
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030203120322033
High-0.62-0.61
Avg-0.98-1.13
Low-1.41-1.68

EPS Growth

EPS Growth20262027202820292030203120322033
High--
Avg--
Low--
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.